Weijun Gu and Yixin Liu contributed equally to this work
Analyze the clinical applicability of glucose metabolism indexes and continuous glucose monitoring data on the qualitative diagnosis of insulinoma.
Involve 22 patients with insulinoma (insulinoma group), 11 patients with hypoglycemia (hypoglycemia group) and 31 people with normal glucose tolerance (control group). HbA1c, fasting blood glucose (FBG), insulin (FINS) and C-peptide (FCP) was tested. Using CGMS to monitor the blood glucose for three consecutive days and selecting the monitoring data of 24 h thereof, figuring out, with the aid of EasyGV Version 9.0, the mean glucose (MG), the standard deviation (SD) of blood glucose, CONGA (continuous overall net glycemic action), J-Index, LI (Lability Index), LBGI (Low Blood Glucose Index), HBGI (High Blood Glucose Index), GRADE (glycaemic risk assessment diabetes equation), MAGE (mean aplitude of glycaemic excursions), M value, MAG (mean absolute glucose).
(1) FBG and LBG of insulinoma group are lower than those of control group and those of hypoglycemia group while FINS and FCP of insulinoma group are markedly higher than those of the other two groups; (2) the MG and CONGA of insulinoma group are lower than those of control group and its indexes like ST, LI, LBGI, GRADE, MAGE, M value and MAG are higher than those of control group; there are differences between the indexes of insulinoma group and those of hypoglycemia group in CONGA (lower than that of hypoglycemia group), LBGI (higher than that of hypoglycemia group), and M value (higher than that of hypoglycemia group). By drawing the ROC curve and calculating Youden index, the cut-off values of LBGI, M value, CONGA are respectively as 4.06, 7.79, 4.38, and the best index of differential diagnosis is LBGI.
Continuous glucose monitoring data can be used to diagnose insulinoma and blood glucose fluctuation indicators such as LBGI, M value, CONGA might be useful to identify insulinoma.
Service FJ, Dale AJ, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976;51:417–29. PubMed
Han J, Zhang F, Bao YQ, et al. Diagnostic value of parameters of glucose metabolism as screening tests for insulinoma. Natl Med J China. 2010;90(16):1093–6.
Liu M, Mu Y, Pan C. Advances in diagnosis and treatment of insulinoma. China J Pract Intern Med. 2006;26(22):1767–9.
Kawasakia A, Suzukia K, Miyamotoa M, Miyamotob T, Yanagic K, Shimizuc M, Hirataa K. Disruptive nocturnal behavior due to insulinoma revealed by continuous glucose monitoring. Eur J Neurol. 2014;21:e46–7. CrossRef
Ding B, Sun R, Shen Y, et al. Application of continuous glucose monitoring system to explore the blood glucose fluctuation model of insulinoma. China Med Herald. 2013;10(29):57–8.
Munir A, Choudhary P, Harrison B, Heller S, Newell-Price John. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol. 2008;68:912–8. CrossRef
Maia FF, Araujo LR. Efficacy of continuous glucose monitoring system to detect unrecognized hypoglycemia in children and adolescents with type 1 diabetes. Arg Bras Endocrinol Metabol. 2005;49(4):569–74. CrossRef
- Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II